Lumexa Imaging (NASDAQ:LMRI) Downgraded to “Hold” Rating by Wall Street Zen

Wall Street Zen cut shares of Lumexa Imaging (NASDAQ:LMRI) from a buy rating to a hold rating in a research note released on Saturday morning.

A number of other brokerages have also recently commented on LMRI. Weiss Ratings raised Lumexa Imaging from a “sell (e)” rating to a “sell (d)” rating in a research report on Thursday, June 25th. Barclays cut their price objective on Lumexa Imaging from $15.00 to $9.00 and set an “overweight” rating on the stock in a report on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat.com, Lumexa Imaging has an average rating of “Moderate Buy” and an average target price of $16.00.

Lumexa Imaging Price Performance

Shares of LMRI opened at $11.58 on Friday. The company has a debt-to-equity ratio of 1.43, a current ratio of 1.40 and a quick ratio of 1.40. The company’s fifty day moving average price is $10.45 and its 200-day moving average price is $11.02. Lumexa Imaging has a 1-year low of $6.45 and a 1-year high of $19.45. The firm has a market capitalization of $1.11 billion and a PE ratio of -19.63.

Insider Activity

In other news, Director Brett Brodnax purchased 35,000 shares of the stock in a transaction that occurred on Tuesday, May 19th. The shares were purchased at an average cost of $7.25 per share, with a total value of $253,750.00. Following the completion of the acquisition, the director owned 62,027 shares of the company’s stock, valued at approximately $449,695.75. This represents a 129.50% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.70% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. Assetmark Inc. purchased a new stake in shares of Lumexa Imaging during the 4th quarter worth about $36,000. Strs Ohio purchased a new position in shares of Lumexa Imaging in the 1st quarter valued at about $38,000. Barclays PLC acquired a new position in Lumexa Imaging in the 4th quarter worth about $133,000. PNC Financial Services Group Inc. purchased a new position in Lumexa Imaging during the first quarter worth approximately $63,000. Finally, Principal Financial Group Inc. grew its holdings in Lumexa Imaging by 1.2% in the first quarter. Principal Financial Group Inc. now owns 664,136 shares of the company’s stock valued at $5,712,000 after purchasing an additional 7,875 shares during the period.

About Lumexa Imaging

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).